Gowling WLG

Gowling WLG‘s life sciences team is well-placed to advise global pharma companies on transactions, notably licensing and collaboration agreements, and complex patent litigation and strategy. The firm’s capabilities extend to health and social care transactions, acting for both providers and investors. Co-heading the practice are Patrick Duxbury, recognised for his IP transactional work, and Robert Breedon, who advises public and private clients on commercial healthcare projects and outsourcing contracts. Paul Inman and Huw Evans handle high-profile patent litigation, while Ian Piggin acts on M&A, investment and structuring matters in the sector. Samantha Myers, Jenny Davies and Matt Hervey are no longer with the firm.